BFC
GWPH

Bedel Financial Consulting’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bedel Financial Consulting’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4
Closed -$1K – 1036
2021
Q1 		$1K Hold
4
– – ﹤0.01% 924
2020
Q4 		$0 Hold
4
– – ﹤0.01% 892
2020
Q3 		$0 Hold
4
– – ﹤0.01% 874
2020
Q2 		$0 Hold
4
– – ﹤0.01% 961
2020
Q1 		$0 Hold
4
– – ﹤0.01% 940
2019
Q4 		$0 Buy
+4
New +$449 ﹤0.01% 796

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Bedel Financial Consulting's GWPH Position: Q2 2021 in Review

Bedel Financial Consulting sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 4 shares — an estimated $1K sold.

Bedel Financial Consulting first reported a position in GWPH in Q4 2019 and held it in 6 quarters. The position peaked at $1K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Bedel Financial Consulting reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Bedel Financial Consulting sold 4 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $1K.
  • Bedel Financial Consulting first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2019 and held it in 6 quarters.
  • Bedel Financial Consulting's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Bedel Financial Consulting's 13F filing for Q2 2021, filed 3 Aug 2021.